# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-23-241886
Filing Date
2023-09-26
Accepted
2023-09-26 07:44:30
Documents
24
Period of Report
2023-09-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d561194d8k.htm iXBRL | 8-K | 27343
2 | EX-99.1 | d561194dex991.htm | EX-99.1 | 16055
3 | EX-99.2 | d561194dex992.htm | EX-99.2 | 12621
7 | GRAPHIC | g561194ex99_2s1g1.jpg | GRAPHIC | 66126
8 | GRAPHIC | g561194ex99_2s2g1.jpg | GRAPHIC | 152249
9 | GRAPHIC | g561194ex99_2s3g1.jpg | GRAPHIC | 133614
10 | GRAPHIC | g561194ex99_2s4g1.jpg | GRAPHIC | 104592
11 | GRAPHIC | g561194ex99_2s5g1.jpg | GRAPHIC | 101575
12 | GRAPHIC | g561194ex99_2s6g1.jpg | GRAPHIC | 118207
13 | GRAPHIC | g561194ex99_2s7g1.jpg | GRAPHIC | 135853
14 | GRAPHIC | g561194ex99_2s8g1.jpg | GRAPHIC | 85185
15 | GRAPHIC | g561194ex99_2s9g1.jpg | GRAPHIC | 33867
16 | GRAPHIC | g561194g0502055550953.jpg | GRAPHIC | 5520
| Complete submission text file | 0001193125-23-241886.txt |  | 1485256

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | rgen-20230926.xsd | EX-101.SCH | 2866
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | rgen-20230926_lab.xml | EX-101.LAB | 18758
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | rgen-20230926_pre.xml | EX-101.PRE | 11721
18 | EXTRACTED XBRL INSTANCE DOCUMENT | d561194d8k_htm.xml | XML | 3507

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 231277168
SIC: 2836 Biological Products, (No Diagnostic Substances)